Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bioprocess Biosyst Eng ; 33(7): 873-83, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20204663

ABSTRACT

The pyruvate dehydrogenase complex was deleted to increase precursor availability in Corynebacterium glutamicum strains overproducing L: -valine. The resulting auxotrophy is treated by adding acetate in addition glucose for growth, resulting in the puzzling fact of gluconeogenic growth with strongly reduced glucose uptake in the presence of acetate in the medium. This result was proven by intracellular metabolite analysis and labelling experiments. To increase productivity, the SugR protein involved in negative regulation of the phosphotransferase system, was inactivated, resulting in enhanced consumption of glucose. However, the surplus in substrate uptake was not converted to L-valine; instead, the formation of up to 289 microM xylulose was observed for the first time in C. glutamicum. As an alternative to the genetic engineering solution, a straightforward process engineering approach is proposed. Acetate limitation resulted in a more efficient use of acetate as cosubstrate, shown by an increased biomass yield Y(X/Ac) and improved L-valine formation.


Subject(s)
Corynebacterium/classification , Corynebacterium/metabolism , Genetic Enhancement/methods , Pyruvate Dehydrogenase Complex/metabolism , Valine/biosynthesis , Pyruvate Dehydrogenase Complex/genetics , Species Specificity , Substrate Specificity
2.
J Comp Neurol ; 518(8): 1157-75, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20148434

ABSTRACT

We followed the development of the nitric oxide-cyclic guanosine monophosphate (NO-cGMP) system during locust embryogenesis in whole mount nervous systems and brain sections by using various cytochemical techniques. We visualized NO-sensitive neurons by cGMP immunofluorescence after incubation with an NO donor in the presence of the soluble guanylyl cyclase (sGC) activator YC-1 and the phosphodiesterase-inhibitor isobutyl-methyl-xanthine (IBMX). Central nervous system (CNS) cells respond to NO as early as 38% embryogenesis. By using the NADPH-diaphorase technique, we identified somata and neurites of possible NO-synthesizing cells in the CNS. The first NADPH-diaphorase-positive cell bodies appear around 40% embryogenesis in the brain and at 47% in the ventral nerve cord. The number of positive cells reaches the full complement of adult cells at 80%. In the brain, some structures, e.g., the mushroom bodies acquire NADPH-diaphorase staining only postembryonically. Immunolocalization of L-citrulline confirmed the presence of NOS in NADPH-diaphorase-stained neurons and, in addition, indicated enzymatic activity in vivo. In whole mount ventral nerve cords, citrulline immunolabeling was present in varying subsets of NADPH-diaphorase-positive cells, but staining was very variable and often weak. However, in a regeneration paradigm in which one of the two connectives between ganglia had been crushed, strong, reliable staining was observed as early as 60% embryogenesis. Thus, citrulline immunolabeling appears to reflect specific activity of NOS. However, in younger embryos, NOS may not always be constitutively active or may be so at a very low level, below the citrulline antibody detection threshold. For the CNS, histochemical markers for NOS do not provide conclusive evidence for a developmental role of this enzyme.


Subject(s)
Locusta migratoria/embryology , Neurons/physiology , Nitric Oxide Synthase/metabolism , Nitric Oxide/metabolism , 1-Methyl-3-isobutylxanthine/pharmacology , Animals , Brain/drug effects , Brain/embryology , Citrulline/metabolism , Cyclic GMP/metabolism , Embryo, Nonmammalian/cytology , Embryo, Nonmammalian/metabolism , Enzyme Activators/pharmacology , Ganglia, Invertebrate/drug effects , Ganglia, Invertebrate/embryology , Ganglia, Invertebrate/metabolism , Indazoles/pharmacology , Locusta migratoria/drug effects , NADPH Dehydrogenase/metabolism , Nerve Regeneration , Nervous System/embryology , Neurites/drug effects , Neurites/physiology , Neurons/drug effects , Neuropil/drug effects , Neuropil/physiology , Phosphodiesterase Inhibitors/pharmacology , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...